Pro-Dex, Inc. (PDEX)
NASDAQ: PDEX · Real-Time Price · USD
39.36
+1.80 (4.79%)
At close: Dec 3, 2025, 4:00 PM EST
39.16
-0.20 (-0.51%)
After-hours: Dec 3, 2025, 4:01 PM EST
Pro-Dex Revenue
Pro-Dex had revenue of $18.53M in the quarter ending September 30, 2025, with 24.43% growth. This brings the company's revenue in the last twelve months to $70.23M, up 23.65% year-over-year. In the fiscal year ending June 30, 2025, Pro-Dex had annual revenue of $66.59M with 23.68% growth.
Revenue (ttm)
$70.23M
Revenue Growth
+23.65%
P/S Ratio
1.76
Revenue / Employee
$388,017
Employees
181
Market Cap
128.39M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 66.59M | 12.75M | 23.68% |
| Jun 30, 2024 | 53.84M | 7.76M | 16.83% |
| Jun 30, 2023 | 46.09M | 4.05M | 9.62% |
| Jun 30, 2022 | 42.04M | 4.01M | 10.55% |
| Jun 30, 2021 | 38.03M | 3.20M | 9.17% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
PDEX News
- 4 weeks ago - Pro-Dex, Inc. Announces Fiscal 2026 First Quarter Results - Accesswire
- 6 weeks ago - Pro-Dex, Inc. Announces Clarification Related to Trading Symbol - Accesswire
- 3 months ago - Pro-Dex, Inc. Announces Fiscal 2025 Fourth Quarter and Full-Year Results - Accesswire
- 7 months ago - Pro-Dex: Crash After Strong Earnings Leads To A Buying Opportunity - Seeking Alpha
- 7 months ago - Pro-Dex, Inc. Announces Fiscal 2025 Third Quarter and Nine-Month Results - Accesswire
- 10 months ago - Q4 2024 Portfolio Update: Growth Has Come Patiently - Seeking Alpha
- 10 months ago - Pro-Dex, Inc. Announces Fiscal 2025 Second Quarter and Six-Month Results - Accesswire
- 1 year ago - PRO-DEX, INC. Announces Fiscal 2025 First Quarter Results - Accesswire